Core Viewpoint - China is committed to an open and win-win approach, continuously optimizing its business environment to instill confidence in multinational companies, including GE Healthcare, to invest and grow in the Chinese market [2][3]. Group 1: Investment and Market Presence - GE Healthcare has established a significant presence in China, with six production bases and over 30 offices, employing more than 7,000 staff and expanding its local R&D team to 1,800 [2]. - The company has launched 150 innovative products in China, indicating that the Chinese market is an essential part of GE Healthcare's global innovation strategy [2]. - Recent investments in innovation in China reflect the company's strong confidence in the market [2]. Group 2: Support and Collaboration - The Chinese government has provided substantial support to GE Healthcare, facilitating its market entry and operations through infrastructure development and talent cultivation [3]. - The emphasis on innovation and intellectual property protection by the Chinese government has encouraged GE Healthcare to localize some of its intellectual property [3]. - GE Healthcare's product development increasingly relies on local design and manufacturing, leveraging China's robust supply chain and technological capabilities [3]. Group 3: Long-term Commitment and Future Outlook - As one of the earliest multinational companies in China, GE Healthcare remains committed to the market, believing that success in China is crucial for its global growth [4]. - The company aims to deepen cooperation with Chinese partners and share development opportunities, promoting collaborative outcomes globally [4]. - There is an optimistic outlook for stable development in US-China relations, which is seen as beneficial for multinational companies operating in both countries [4].
“在中国,我感受到‘敢想敢干’的精神”(见证·中国机遇)